Drug Mech Exam 1

Card Set Information

Drug Mech Exam 1
2011-02-04 21:37:45
Drug Mech

Drug mech Lecture: Chemotherapeutics
Show Answers:

  1. What is an antibiotic?
    An antibacterial agent, is a molecule (synthetic or natural) capable of selectively inhibiting growth or survival of one or more species of micro-organism at low concentrations.
  2. MIC value
    Minimum Inhibatory Concentration of an antibiotic, concentration which completely prevents the growth or survival of a micro-organism

    Lowest concentration of an antibiotic to produce an effect

    MIC measures potency(concentration)

    dec. MIC, inc. potency
  3. What is a Clinical Dose?
    Dose to acheive a plasma concentration of ~ 4 to 8 times the MIC value.

    Clinical dose must be associated with minimum or no toxicity to patient.

    Dose of antibiotic used to treat infection in patient must have a high selectivity to bacterial cells for toxicity.
  4. What is a Bacteriostatic antibiotic?
    antibiotic that inhibits bacterial growth at the clinical dose

    Inhibits bacterial cell growth, cell division, but bacteria is still alive
  5. What is a Bactericidal antibiotic?
    antibiotic that kills the bacteria at the clinical dose
  6. Examples of Bacteriostatic antibiotics?
    • Tetracyclines
    • Sulfonamides
  7. Examples of Bactericidal antibiotics?
    • Penicillins
    • Aminoglycosides
    • Polypeptides
    • Quinolones
  8. Is it possible to predict the effect of the antibiotic from the mechanism of action?
    Not really, because there are other factors invovled that affect the "effect" of the antibiotic

    ex: tetracycline and aminoglycosides have same outcomes, but different binding sites, concentrations, doses.
  9. From the mechanism of action can we predict the effects of antibiotics?
    Not really becuase two drugs can be -cidals but have different mechanism of actions
  10. What is the Bacteriostatic Effect of antibiotics?
    At the clinical dose, will inhibit cell division (growth) of microorganism. Bacteria will survive, but will stop multiplying.

    Immune system will then kill off the bacteria
  11. What is the Bactericidal Effect of an antibiotic?
    At the clinical dose, will inhibit the survival of microbes. (kills)
  12. What is Susceptibility?
    The prerequisite of a bacterial strain for the antibiotic's ability to exhibit its static/cidal effect.

    The antibiotic will work against the bacteria.
  13. Factors that determine the effect (static/cidal) of an antibiotic:
    • 1. Concentration (Dose)
    • 2. Mechanism of Action
    • 3. Microbial Susceptibility/Resistance
    • 4. Microbial Species

    (Concentration (is most impt) and Mechanism of Action are the two most important)
  14. Is it possible for ALL antibiotics to exhibit a bactericidal effect regardless of thier mechanisms of action?
    YES, if the antibiotic is given in high enough doses to kill all bacterial cells
  15. Is it possible for an antibiotic to exhibit BOTH bacteriostatic and -cidal effects against a bacterial strain?
    Yes, majority of antibiotics have a -static and -cidal doses.
  16. Is it possible for an antibiotic to exhibit ONLY bactericidal effect against a bacterial strain (no static effect even at lower concentraions)?
    Yes, for only a few antibiotics, since their mechanism of actions are devestating to the bacterial cells.

    ex: inhibiting cell wall synthesis (penicillin, vancomycin, polypeptides, polymixin B)

    Bacteria must be susceptible withOUT resistance
  17. Is it possible for a known -cidal antibiotic against a bacterial strain, to suddenly become -static against the strain at the same clinical dose?
    YES, because of antimicrobial resistance. However, only in drugs with 2 effects or "targets."

    ex: Senersid, antibiotic with 2 drug components, inhibits by 2 mechanisms of actions. Resistance at one binding site but NOT the other, therefore more "static" effect and no longer "cidal."
  18. How to decide an antibiotic as a -cidal or
    -static clinical dose?
    -If the difference between the "static" and "cidal" dose is HUGE, this means the cidal does is toxic to patients, and the clinical dose should be the "static" dose.

    -If the difference between the "static" and "cidal" dose is SMALL, this means the cidal dose is not very toxic to patients, and the clinical dose should be "cidal" dose.
  19. What are the clinical implications of STATIC antibiotics?
    • Use "statics" if:
    • -treating mild infections in outpatients

    -ONLY used in immunocompetent patients

    -Patients should NOT skip doses or stop taking (regardless if static or cidal drug)
  20. What are clinical implications of CIDAL antibiotics?
    • Use "cidals" if:
    • -Patients have severe/life threatening infections

    • -Patients are immunoCOMPROMISED
    • -
    • -Patients should NOT skip doses or stop taking (regardless if static or cidal drug)
  21. What is a Narrow-spectrum antibiotic?
    affects only a limited number of baterial species/strains. Either just gram pos or just gram negs.

    Minimizes the emergence of microbial resistance

    Should always be used when possible because they are cheaper and lead to lesser resistance.
  22. What is a Broad-spectrum antibiotic?
    affects a large number of bacterial strains/species. Includes gram pos and gram negs.

    Use only when ABSOLUTELY NECCESSARY, to minimize resistance.
  23. What is combination antimicrobial therapy?
    invovles use of two or more antibiotics to treat infection
  24. Advantages of combination therapy:
    1. Provide broad spectrum empiric (inital) therapy in very ill patients

    2. Treat polymicrobial (mixed) infections

    3. Obtain ENHANCED activity for therapy (synergism)
  25. Disadvantages of combined antimicrobial therapy:
    1. increased overall toxicity

    2. increased cost

    3. Antagonism (some combintions=antagonistic)

    4. Emergence of microbial resistance through selection
  26. What is Synergism?
    Enhanced effect of two drugs when given together, vs. each drug by itself.

    Marked by FOURFOLD or greater REDUCTION in MIC of each drug when used in combination vs. when used alone. (dec. MIC, INC. Potency)

    FIC <0.5
  27. What is Antagonism?
    Combined INHIBATORY or killing effects of two or more drug. Effects are significantly LESS than expected with used together vs. when used alone.

    FIC >4
  28. What is Indifference?
    COMBINED inhibitory or killing effect is the same when used together or alone.

    FIC between 0.5 and 4 (0.5 <x>4)
  29. What is FIC?
    Fractional Inhibitory Concentration Index

    FIC index = FICa + FICb

    • FICa=MIC drug a in combination
    • MIC drug a alone
    • FICb=MIC drug b in combination
    • MIC drug b alone
  30. What are the FIC values:
    • Synergism: <0.5
    • Antagonism: >4
    • Indifference: between 0.5 and 4
  31. What are the Mechanisms of SYNERGISTIC actions?
    1. Blockage of sequential Steps in a metabolic pathway (combination antibiotic with 1 antibiotic inhibiting a step in a pathway, and the 2nd antibiotic inhibiting the next right after in the SAME pathway)

    2. Inhibition of Enzymatic Inactivation (ex: some antibiotics inhibit certain enzymes in a bacterial cell that can inactivate antibiotics. Clavulanic acid inactivates B-lactamase to allow Amoxicillin to work)

    3. Enhancement of antimicrobial agent uptake by bacterial cells (Penicillin breaks down cell wall to allow aminoglycosides to work; amphitercin pokes holes in fungi to allow fluoroquinolones to inhibit DNA/RNA synthesis)

    4. Binding of ONE antibiotic ENHANCES the binding of another antibiotic (Senersid: binding of first drug enhances binding of second drug)
  32. What are the mechanisms of ANTAGONISTIC actions?
    1. Inhibition of CIDAL drugs by STATIC drugs (static drugs stop cell division, but many cidal drugs need the cell to divide in order for it to work.) BUT keep in mind the MECHANISM OF ACTION of static/cidal drugs. ex: tetracyclines (static) and aminoglycosides (cidal), but they are INDEFERENT.

    2. Induction of enzymatic inactivation. ex: some antibiotics induce production of certain bacterial enzymes that may inactivate the second antibiotic. ex: Penicillin (B-lactam) and Imipenem (induces B-lactamases)
  33. What are some problems with Microbial Resistance?
    -resistance is an increasingly important public health concern and factor in ALL hospital-acquired (nosocomial) infections and community acquired infections.

    -Microbial resistance is EVOLUIONARY.

    -Rapid emergence and dissemination of MDR strains.
  34. What are some Contributing Factors to Microbial Resistance?
    1. Microbes ADAPT quickly to new environments

    2. Microbes have SMALL number of genes, and single random gene mutations can have large impact on properties

    3. Microbes replicate fast, and evolve fast

    4. A mutation that helps a microbe survive can quickly become predominate throughout population

    5. Microbes can get genes, including resistant genes, by direct transfer from their own species and from other species

    6. Widespread and Inappropriate use of antibiotic theraypy (antibiotic use for viral infections, improper dosage, lack of bacterial information on organism, use of antibiotic in animal feed, antibiotics as OTC products in other parts of the world)

    7. Patient NONCOMPLIANCE
  35. Why is it relevant to the U.S. that antibiotics can be OTC in other parts of the world?
    Some people order their drugs from out of the country, and microbes can be easily transfered with international travels.
  36. What are the mechanisms of Microbial Resistance?
    1. Drug inactivation by enzymes- bacteria can make enzyme that inactivates the antibiotic

    2. Target Modification (chromosomal mutation)- result of spontaneous mutation on chromosome, leading to ability of bacteria to change chemistry of the "binding site" for the antibiotic.

    3. Alteration in Target Accessibility- reducing permeability or increasing efflux of drugs with pumps. bacteria deny drug access to target inside the cell.

    4. Development of Altered Metabolic Pathways- bacteria finds way to bypass the area in the metabolic pathway that is targeted by the antibiotic (bypass step that drug inhibits)

    A combination of two or more mechanisms can exist in a single bacterial strain.
  37. What are the origins of Microbial Resistance?
    1. Nongenetic origin (nonmultiplying organism)

    2. Genetic origin (resistant genes)
  38. What is nongenetic origin of microbial resistance?
    occurs in non-multiplying organisms, when bacteria stops dividing, they become harder (more resistant) to kill by mostly all antibiotics

    EX: TB can be dormant for years in lung tissues, once immune system decreases, TB can multiply again and now can be treated with antibiotics
  39. What are the two Genetic origins in Microbial Resistance?
    1. Chromosonal Resistance - gene mutation resistance located on chromosomes

    2. Extrachromosomal Resistance - gene resistance located on plasmid
  40. What is Chromosonal Resistance?
    -Caused by a spontaneous mutation, occurs on bacterial chromosome

    -Resistance becomes predominant in microbial population through SELECTION

    -Lead mainly to TARGET MODIFICATION as the resistance mechanism
  41. What is Extrachromosomal Resistance?
    -Transfered by R-Factor (plasmids that contain genes encode for resistance)

    -Leads mainly to DRUG INACTIVATION BY ENZYMES as the resistance mechanism
  42. Types of Mechanisms to transfer R-Factors:
    1. Transformation - direct insertion of R-Factor into a bacterial cell (not very common)

    2. Transduction - R Factor are transfered via a virus

    3. COnjugation -mating between bacterial cells (between species or non species can occur)*the most important mechanism that contribut to resistance

    4. Transposition - transfer of R Factor when the gene is located on "transposons" (jumping genes- change locations) R Factor will jump and be incorporated in choromosmes leading to Chromosomal resistance